Volume 16, Issue 1, January 2019 - First Report Managed Care
01/28/2019
Jeff Craven
Drug shortages have been more prevalent in recent years. Now, the US Food and Drug Administration (FDA), pharmaceutical companies, and other stakeholders are beginning to work together to open conversations about the issue’s causes and...
Drug shortages have been more prevalent in recent years. Now, the US Food and Drug Administration (FDA), pharmaceutical companies, and other stakeholders are beginning to work together to open conversations about the issue’s causes and...
Drug shortages have been more...
01/28/2019
First Report Managed Care
Formulary Frontlines®
01/28/2019
Edan Stanley
Patients with psoriasis have an increased risk for metabolic syndrome, including obesity, diabetes, and hyperlipidemia, with an increased overall mortality risk in patients with severe psoriasis.
Patients with psoriasis have an increased risk for metabolic syndrome, including obesity, diabetes, and hyperlipidemia, with an increased overall mortality risk in patients with severe psoriasis.
Patients with psoriasis have an...
01/28/2019
First Report Managed Care
News Connection
01/28/2019
According to the Department of Veteran Affairs (VA), the results of a recent customer experience survey shows an average 2.4% increase in veteran trust of VA hospitals during fiscal year 2018.
According to the Department of Veteran Affairs (VA), the results of a recent customer experience survey shows an average 2.4% increase in veteran trust of VA hospitals during fiscal year 2018.
According to the Department of...
01/28/2019
First Report Managed Care
News Connection
01/28/2019
According to a recent study, Veteran Health Administration (VHA) hospitals provided the best care in most hospital referral regions and rarely provided the worst care.
According to a recent study, Veteran Health Administration (VHA) hospitals provided the best care in most hospital referral regions and rarely provided the worst care.
According to a recent study,...
01/28/2019
First Report Managed Care
News Connection
01/28/2019
Compared with standard of care alone, added liraglutide resulted in an additional 0.67 life-years in patients with type 2 diabetes at elevated cardiovascular risk with little to no budget impact, according to a study published online in...
Compared with standard of care alone, added liraglutide resulted in an additional 0.67 life-years in patients with type 2 diabetes at elevated cardiovascular risk with little to no budget impact, according to a study published online in...
Compared with standard of care...
01/28/2019
First Report Managed Care
News Connection
01/28/2019
Bill De Blasio, mayor of New York City, is expected to unveil a new health plan for all city residents that will guarantee care regardless of their ability to pay or their immigration status.
Bill De Blasio, mayor of New York City, is expected to unveil a new health plan for all city residents that will guarantee care regardless of their ability to pay or their immigration status.
Bill De Blasio, mayor of New...
01/28/2019
First Report Managed Care
News Connection
01/28/2019
In a recent press release, Pfizer Inc and GlaxoSmithKline plc (GSK) announced they have entered into an agreement to create a premier global consumer health care company.
In a recent press release, Pfizer Inc and GlaxoSmithKline plc (GSK) announced they have entered into an agreement to create a premier global consumer health care company.
In a recent press release,...
01/28/2019
First Report Managed Care
News Connection
01/28/2019
Walgreens Boots Alliance, Inc and Verily, an Alphabet company, have announced they will collaborate on multiple projects in a new partnership. Under a broad agreement, the companies will work to improve health outcomes for patients with...
Walgreens Boots Alliance, Inc and Verily, an Alphabet company, have announced they will collaborate on multiple projects in a new partnership. Under a broad agreement, the companies will work to improve health outcomes for patients with...
Walgreens Boots Alliance, Inc...
01/28/2019
First Report Managed Care
News Connection
01/28/2019
Bristol-Myers Squibb has announced it will buy Celgene and create a leading specialty biopharma company. The cash and stock deal is valued at $74 billion.
Bristol-Myers Squibb has announced it will buy Celgene and create a leading specialty biopharma company. The cash and stock deal is valued at $74 billion.
Bristol-Myers Squibb has...
01/28/2019
First Report Managed Care
01/28/2019
Dean Celia
The administration is ready to make changes, but which will come first? Managed care experts recently combed through a 119-page government report offering ideas for health care reform to analyze specific recommendations and predict what might...
The administration is ready to make changes, but which will come first? Managed care experts recently combed through a 119-page government report offering ideas for health care reform to analyze specific recommendations and predict what might...
The administration is ready to...
01/28/2019
First Report Managed Care
01/28/2019
Mary Beth Nierengarten
The “Inadmissibility on Public Charge Grounds” Proposed Rule presents a series of changes that impact both immigrants and non-immigrants. As public comment period has ended, what can we expect?
The “Inadmissibility on Public Charge Grounds” Proposed Rule presents a series of changes that impact both immigrants and non-immigrants. As public comment period has ended, what can we expect?
The “Inadmissibility on Public...
01/28/2019
First Report Managed Care
01/28/2019
Mary Beth Nierengarten
For nearly 2 years, since CMS’ final rule was released, states, health plans, and providers have operated under its statutes and discovered difficulties. A rewrite offers a chance to correct those issues.
For nearly 2 years, since CMS’ final rule was released, states, health plans, and providers have operated under its statutes and discovered difficulties. A rewrite offers a chance to correct those issues.
For nearly 2 years, since CMS’...
01/28/2019
First Report Managed Care
Conference Insider
01/28/2019
A study presented at ASHP 2018 Midyear Clinical Meeting & Exhibition compared the cost-effectiveness of betrixaban to enoxaparin in patients presenting with venous thromboembolism (VTE.)
A study presented at ASHP 2018 Midyear Clinical Meeting & Exhibition compared the cost-effectiveness of betrixaban to enoxaparin in patients presenting with venous thromboembolism (VTE.)
A study presented at ASHP 2018...
01/28/2019
First Report Managed Care
Conference Insider
01/28/2019
A presentation at ASHP 2018 Midyear Clinical Meeting & Exhibition showed success in tracking operative clinical progress, opiod use and pain scores, and chronic postsurgal pain risk factors in veterans by utilizing new health information...
A presentation at ASHP 2018 Midyear Clinical Meeting & Exhibition showed success in tracking operative clinical progress, opiod use and pain scores, and chronic postsurgal pain risk factors in veterans by utilizing new health information...
A presentation at ASHP 2018...
01/28/2019
First Report Managed Care
Conference Insider
01/28/2019
An evaluative study presented at the ASHP 2018 Midyear Clinical Meeting & Exhibition explained ways one hospital combats drug shortages using preventive measures.
An evaluative study presented at the ASHP 2018 Midyear Clinical Meeting & Exhibition explained ways one hospital combats drug shortages using preventive measures.
An evaluative study presented at...
01/28/2019
First Report Managed Care
Conference Insider
01/28/2019
A study presented at ASH Annual Meeting 2018 would suggest that ibrutinib is a strong option for patients aged 65 and older in the prevention of relapse in patients with chronic lymphocytic leukemia (CLL).
A study presented at ASH Annual Meeting 2018 would suggest that ibrutinib is a strong option for patients aged 65 and older in the prevention of relapse in patients with chronic lymphocytic leukemia (CLL).
A study presented at ASH Annual...
01/28/2019
First Report Managed Care
Conference Insider
01/28/2019
In a study presented at the ASH Annual Meeting 2018 in San Diego, researchers asked, “Are patients willing to trade off efficacy for tolerability?” in reference to the treatment of relapsed/refractory multiple myeloma (RRMM).
In a study presented at the ASH Annual Meeting 2018 in San Diego, researchers asked, “Are patients willing to trade off efficacy for tolerability?” in reference to the treatment of relapsed/refractory multiple myeloma (RRMM).
In a study presented at the ASH...
01/28/2019
First Report Managed Care
Conference Insider
01/28/2019
Researchers at the ASH Annual Meeting 2018 in San Diego presented that young adult patients diagnosed with accute lymphoblastic leukemia (ALL) being treated at specialized cancer centers (SCCs) are spending more for inpatient care and...
Researchers at the ASH Annual Meeting 2018 in San Diego presented that young adult patients diagnosed with accute lymphoblastic leukemia (ALL) being treated at specialized cancer centers (SCCs) are spending more for inpatient care and...
Researchers at the ASH Annual...
01/28/2019
First Report Managed Care
